Tag: Daniel Karelitz
Three firms act on BioNTech’s USD950m China partner buyout
A&O Shearman, Goodwin, and Conyers are advising BioNTech on its $950M buyout of a Chinese cancer drug partner to rival Merck
Goodwin and Nelson Mullins in USD685m Crown LNG SPAC merger
Goodwin Procter and Nelson Mullins Riley & Scarborough have assisted the USD685 million merger of the Oslo-based liquefied natural gas (LNG) offshore terminal
LATEST ON LAW.ASIA
CBLJ Forum Beijing 2026
More than 70 legal experts and industry leaders shared insights at our Beijing forum, exploring solutions to businesses’ key legal challenges
